HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 35 filers reported holding HEPION PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,244,552 | +159.4% | 1,602,772 | +0.3% | 0.00% | – |
| Q4 2022 | $479,748 | -40.4% | 1,597,566 | +0.3% | 0.00% | – |
| Q3 2022 | $805,000 | -12.9% | 1,592,781 | -1.4% | 0.00% | – |
| Q2 2022 | $924,000 | -55.6% | 1,614,716 | +0.1% | 0.00% | – |
| Q1 2022 | $2,080,000 | +12.4% | 1,612,627 | -0.7% | 0.00% | – |
| Q4 2021 | $1,850,000 | -26.0% | 1,623,905 | -0.6% | 0.00% | – |
| Q3 2021 | $2,500,000 | -23.5% | 1,634,012 | -1.0% | 0.00% | – |
| Q2 2021 | $3,266,000 | +3.4% | 1,649,929 | -3.9% | 0.00% | – |
| Q1 2021 | $3,158,000 | +20.7% | 1,716,168 | +43.7% | 0.00% | – |
| Q4 2020 | $2,616,000 | +1284.1% | 1,194,434 | +1867.1% | 0.00% | – |
| Q3 2020 | $189,000 | +9.2% | 60,722 | 0.0% | 0.00% | – |
| Q2 2020 | $173,000 | +61.7% | 60,722 | 0.0% | 0.00% | – |
| Q1 2020 | $107,000 | -67.1% | 60,722 | 0.0% | 0.00% | – |
| Q4 2019 | $325,000 | – | 60,722 | +57184.9% | 0.00% | – |
| Q3 2019 | $0 | – | 106 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PVG ASSET MANAGEMENT CORP | 189,616 | $375,439,000 | 1.17% |
| Ikarian Capital, LLC | 1,365,059 | $2,703,000 | 0.22% |
| Altium Capital Management LP | 446,000 | $883,000 | 0.20% |
| ASSET MANAGEMENT CORP /IL/ /ADV | 91,500 | $181,000 | 0.10% |
| Virtu Financial LLC | 113,869 | $225,000 | 0.02% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 10,000 | $20,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 155,069 | $307,000 | 0.01% |
| McAdam, LLC | 55,978 | $86,000 | 0.01% |
| Moloney Securities Asset Management, LLC | 27,340 | $54,000 | 0.01% |
| Allen Capital Group, LLC | 23,685 | $47,000 | 0.01% |